Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Q3 Trading Update

6 Nov 2015 07:00

RNS Number : 7178E
Synthomer PLC
06 November 2015
 

November 6th 2015

Synthomer plc

Q3 Trading Update

Continued progress, in line with full year expectations

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the third quarter ended September 30th, 2015.

Trading

Europe and North America

The Europe and North America segment has continued to perform in line with the positive trends seen during the first half of the year. Whilst volumes were lower than Q3 2014 due to ongoing weakness in our Paper business, we continued to make good progress driven by a further improvement in Construction and Coatings and Functional Polymers. The recent falls in raw material prices helped to deliver a modest improvement in unit margins in Q3 over Q2 and the comparable period in 2014.

Asia and Rest of World

The Asia and Rest of World segment has continued to perform strongly in Q3, with both volumes and unit margins higher than in Q2 and Q3 2014. This ongoing momentum reflects a further rise in volumes and unit margins in our Nitrile business. Our principal revenue streams and raw material costs in Asia are US dollar denominated, and accordingly the recent volatility in the Malaysian Ringgit has a limited impact on the reported operating profit in Sterling.

Financial Position

Group debt increased from £77.2m to £94.8m following the Final Ordinary and Special dividend payments of £42.8m on 3 July 2015, offset by continued strong cash generation of £26.0m during the period.

The Group balance sheet remains strong with the net debt/ EBITDA ratio below 1x.

Outlook

Overall, the Board's expectations for Full Year 2015 remain unchanged.

Looking further ahead, in Europe and North America, our strategy continues to focus on innovation, margin improvement and tight cost control to drive performance. Consequently, we expect this segment to continue at similar volumes and margins through 2016.

As stated in our interim results, a number of Asian Nitrile producers, including Synthomer, have announced plans to increase capacity during the latter part of 2016 and early 2017. Whilst we are confident of continued growth in the market and strong demand going into next year, we expect this planned capacity increase to impact the supply/ demand balance during the second half of 2016 leading to similar net volumes and margins to 2015 for the year as a whole. 

-ENDS-

ENQUIRIES:

Calum MacLean, Chief Executive Officer

Charles Armitstead

Stephen Bennett, Chief Financial Officer

Pendomer Communications

Tel: + 44 1279 436211

Tel: + 44 20 3603 5220

 

The Company will hold a conference call for investors and analysts at 0800 BST today. 

Please dial + 44 20 3426 2890 to gain access to the call.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBABTTMBIMBBA
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.